BDX Becton Dickinson & Co
- 235.000
- +1.420+0.61%
- 237.000
- +2.000+0.85%
Becton Dickinson & Co News
Becton Dickinson Is Maintained at Overweight by Barclays
Becton Dickinson Is Maintained at Overweight by Barclays
Becton Dickinson Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/06/2024 32.09% Barclays $305 → $312 Maintains Overweight 02/05/2024 29.12% Barclays $301 → $305 Maintai
11 Best Recession Dividend Stocks To Buy
Barclays Adjusts Price Target on Becton, Dickinson to $312 From $305, Keeps Overweight Rating
Becton, Dickinson (BDX) has an average outperform rating and a price target range of $240 to $325, according to analysts polled by Capital IQ. Price: 237.00, Change: +2.32, Percent Change: +0.99
Becton Dickinson (BDX) Receives a Buy From Barclays
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
Becton, Dickinson and Company (NYSE:BDX) Q2 2024 Earnings Call Transcript
TD Cowen Adjusts Price Target on Becton, Dickinson and Company to $260 From $271
Becton, Dickinson and Company (BDX) has an average rating of outperform and price targets ranging from $240 to $325, according to analysts polled by Capital IQ.
Peripheral Vascular Devices Market Is Projected to Grow at a CAGR of 8.5% by 2034: Visiongain
Stock Market News for May 3, 2024
Q2 2024 Becton Dickinson and Co Earnings Call
Becton, Dickinson Files for Automatic Mixed Securities Shelf
Evercore ISI Raises Becton, Dickinson and Company Price Target to $282 From $280
Becton, Dickinson and Company (BDX) has an average outperform rating and price target range of $240 to $325, according to analysts polled by Capital IQ. Price: 232.52, Change: -1.21, Percent Change: -
Becton & Dickinson 'Is Well On Its Way To Achieving 2025 Commitments,' Analyst Optimistic On Outlook
On Thursday, BD (Becton, Dickinson and Company) (NYSE:BDX) reported second-quarter sales of $5.04 billion, up 4.6% year over year, in line with the consensus."Second quarter performance reflects our s
Research Alert: CFRA Reiterates Hold Opinion On Shares Of Becton, Dickinson And Company
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target price by $1
Earnings Call Summary | Becton Dickinson & Co(BDX.US) Q2 2024 Earnings Conference
The following is a summary of the Becton, Dickinson and Company (BDX) Q2 2024 Earnings Call Transcript:Financial Performance:Becton, Dickinson and Company reported Q2 2024 revenue of $5 billion, indic
Becton, Dickinson and Company (BDX) Q2 2024 Earnings Call Transcript
Becton, Dickinson and Company (BDX) Q2 2024 Earnings Call Transcript
Sector Update: Health Care Stocks Mixed Premarket Thursday
Health care stocks were mixed premarket Thursday as the iShares Biotechnology ETF (IBB) was inactive and the Health Care Select Sector SPDR Fund (XLV) was up 0.4% recently. Becton, Dickinson (BDX) adv
Sector Update: Health Care
Health care stocks were mixed premarket Thursday, with the iShares Biotechnology ETF (IBB) inactive and the Health Care Select Sector SPDR Fund (XLV) up 0.3%. Becton, Dickinson (BDX) shares were up ov
Becton Dickinson Shakes Up 2024 Outlook After Growing 2Q Sales, Earnings
By Dean Seal Becton Dickinson cut its fiscal 2024 revenue guidance while raising its adjusted annual earnings forecast after reporting top and bottom line growth for its second quarter. The medical-
Analysis
Price Target
No Data
